Wing Venture Capital
An Assay Development Scientist at Glyphic Biotechnologies designs and performs experiments to advance single-molecule protein sequencing. The role involves library preparation, assay development, and collaboration across multidisciplinary teams.
Headquarters
Palo Alto, California, United States
Company Size
1-10 employees
Founded
2013
Wing Venture Capital (Wing VC) is an early-stage investor and long-term company builder that equips founders with resources and partnership to build transformative technology companies. Wing focuses on the AI-first technology stack, investing across areas such as autonomous apps, data, AI, and PLG. The firm is headquartered in Palo Alto, CA and also supports portfolio companies through its Founder Success Platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Wing Venture Capital.
13% above the average for this role
2021 Most Disruptive MBA Startups: Glyphic Biotechnologies, Stanford GSB
Dec 6, 2021
Assay Integration Lead
Glyphic Biotechnologies
Scientist or Senior Scientist
Glyphic Biotechnologies
Scientist / Senior Scientist, Assay Development (Reagents)
Glyphic Biotechnologies
Scientist
Glyphic Biotechnologies
Staff / Senior Scientist, Assay Development (Chemistry)
Glyphic Biotechnologies
Assay Development Research Scientist I
FULGENT THERAPEUTICS LLC